Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Angiotensin receptor/Neprilysin inhibitor effects in CRTd non-responders: From epigenetic to clinical beside.
Sardu C, Massetti M, Scisciola L, Trotta MC, Santamaria M, Volpicelli M, Ducceschi V, Signoriello G, D'Onofrio N, Marfella L, Casolaro F, Amico MD', Ruocco A, Balestrieri ML, Mauro C, Rafaniello C, Capuano A, Paolisso G, Marfella R. Sardu C, et al. Among authors: marfella l. Pharmacol Res. 2022 Aug;182:106303. doi: 10.1016/j.phrs.2022.106303. Epub 2022 Jun 10. Pharmacol Res. 2022. PMID: 35697289 Free article.
Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment.
D'Onofrio N, Sardu C, Trotta MC, Scisciola L, Turriziani F, Ferraraccio F, Panarese I, Petrella L, Fanelli M, Modugno P, Massetti M, Marfella LV, Sasso FC, Rizzo MR, Barbieri M, Furbatto F, Minicucci F, Mauro C, Federici M, Balestrieri ML, Paolisso G, Marfella R. D'Onofrio N, et al. Among authors: marfella lv. Mol Metab. 2021 Dec;54:101337. doi: 10.1016/j.molmet.2021.101337. Epub 2021 Sep 7. Mol Metab. 2021. PMID: 34500107 Free PMC article.
Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study.
Marfella R, D'Onofrio N, Sardu C, Scisciola L, Maggi P, Coppola N, Romano C, Messina V, Turriziani F, Siniscalchi M, Maniscalco M, Boccalatte M, Napolitano G, Salemme L, Marfella LV, Basile E, Montemurro MV, Papa C, Frascaria F, Papa A, Russo F, Tirino V, Papaccio G, Galdiero M, Sasso FC, Barbieri M, Rizzo MR, Balestrieri ML, Angelillo IF, Napoli C, Paolisso G. Marfella R, et al. Among authors: marfella lv. Diabetes Obes Metab. 2022 Jan;24(1):160-165. doi: 10.1111/dom.14547. Epub 2021 Oct 1. Diabetes Obes Metab. 2022. PMID: 34494705 Free PMC article. No abstract available.
GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes.
Marfella R, Prattichizzo F, Sardu C, Rambaldi PF, Fumagalli C, Marfella LV, La Grotta R, Frigé C, Pellegrini V, D'Andrea D, Cesaro A, Calabrò P, Pizzi C, Antonicelli R, Ceriello A, Mauro C, Paolisso G. Marfella R, et al. Among authors: marfella lv. Cardiovasc Diabetol. 2024 Jan 6;23(1):10. doi: 10.1186/s12933-023-02118-6. Cardiovasc Diabetol. 2024. PMID: 38184582 Free PMC article.
SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes.
Marfella R, Sardu C, D'Onofrio N, Fumagalli C, Scisciola L, Sasso FC, Siniscalchi M, Marfella LV, D'Andrea D, Minicucci F, Signoriello G, Cesaro A, Trotta MC, Frigé C, Prattichizzo F, Balestrieri ML, Ceriello A, Calabrò P, Mauro C, Del Viscovo L, Paolisso G. Marfella R, et al. Among authors: marfella lv. BMC Med. 2023 Feb 24;21(1):71. doi: 10.1186/s12916-023-02781-2. BMC Med. 2023. PMID: 36829203 Free PMC article.